dactinomycin has been researched along with tamoxifen in 53 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (18.87) | 18.7374 |
| 1990's | 17 (32.08) | 18.2507 |
| 2000's | 18 (33.96) | 29.6817 |
| 2010's | 8 (15.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hansch, C; Khwaja, TA; Selassie, CD | 1 |
| Bacsó, Z; Cianfriglia, M; Fenyvesi, F; Goda, K; Kappelmayer, J; Lustyik, G; Nagy, H; Szabó, G; Szilasi, M | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ghosh, I; Manoharlal, R; Prakash, O; Prasad, R; Puri, N; Sharma, M | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Morley, P; Schwartz, JL; Tsang, BK; Vanderhyden, BC; Whitfield, JF | 1 |
| Allen, MC; Gregg, DW; Nett, TM | 1 |
| Gyling, M; Heuson, JC; Leclercq, G | 1 |
| Albain, KS; Le Beau, MM; Schumacher, H; Ullirsch, R | 1 |
| Brunat-Mentigny, M; Manoukian, A; Nourissat, C; Patricot, LM; Tachon, G | 1 |
| Hayashi, K; Kida, N; Mori, K; Yoshimura, T | 1 |
| Degani, H; Neeman, M | 1 |
| Dubik, D; Shiu, RP | 1 |
| Bradley, S; Cooke, TG; De Sousa, BA; George, WD; Holt, S; Leinster, SJ | 1 |
| Ahmann, FR; Jones, SE; Moon, TE | 1 |
| Moertel, CG | 1 |
| Bourtourault, M; Haras, D; Jouan, P; Mahoudo, H; Samperez, S | 1 |
| Morris, ID; Stephen, TM | 1 |
| Horwitz, KB; McGuire, WL | 1 |
| Carpentier, AF; Chantelard, JV; Henin, D; Poisson, M | 1 |
| Agresti, M; Fine, RL; Roberts, S; Safa, AR | 1 |
| Borrás, M; el Khissiin, AH; Gol-Winkler, R; Hardy, L; Leclercq, G; Legros, N; Lempereur, F | 1 |
| Fujita, S; Inada, K; Matsuo, S; Nakashima, Y; Nomura, K; Ogawa, M; Saishoji, T; Takano, S; Yamashita, J; Yamashita, S | 1 |
| Abi-Younes, S; Dingaan, B; Farhat, MY; Ramwell, PW; Vargas, R | 1 |
| Jackson, JG; Lee, AV; Weng, CN; Yee, D | 1 |
| Cantabrana, B; Hidalgo, A; Revuelta, MP | 1 |
| Amir-Zaltsman, Y; Kaye, AM; Kohen, F; Mor, G; Sömjen, D; Tordjman, K; Waisman, A | 1 |
| Hanley, MR; Villablanca, AC | 1 |
| Berthaut, I; Blanchere, M; Mestayer, C; Mowszowicz, I; Portois, MC | 1 |
| El Khissiin, A; Laios, I; Larsimont, D; Leclercq, G; Legros, N; Querton, G; Seo, HS | 1 |
| Lu, R; Serrero, G | 1 |
| Han, HJ; Lee, YH; Park, SH | 1 |
| Leung, SW; Man, RY; Quan, A; Teoh, H | 1 |
| Kass, L; Luque, EH; Montes, GS; Muñoz de Toro, M; Ramos, JG; Rodriguez, H; Varayoud, J | 1 |
| Calabro, SP; Carey, DJ; Filler, TA; Gardner, RM; Russo, LA | 1 |
| Dutertre, M; Mancini, MA; Mancini, MG; O'Malley, BW; Patel, K; Smith, CL; Stenoien, DL | 1 |
| Chen, Z; Horiguchi, J; Jordan, VC; Levenson, AS; Liu, H; MacGregor Schafer, J | 1 |
| Clarke, M; Gatzemeier, W; Rauschecker, H; Recht, A | 1 |
| Murdoch, WJ; Van Kirk, EA | 1 |
| Alkhalaf, M; El-Mowafy, AM | 1 |
| de Boto, MJ; Hidalgo, A; Martínez, C; Sánchez, M | 1 |
| Navarrete, E; Perusquía, M | 1 |
| Burns, DJ; Langdon, SP; Macleod, KG; O'Donnell, AJ; Smyth, JF | 1 |
| Anak, S; Bilgic, B; Güler, N; Gun, F; Ones, U; Saribeyoglu, E; Tamay, Z; Yilmazbayhan, D | 1 |
| Chen, ZY; Huang, Y; Ko, WH; Laher, I; Leung, FP; Leung, HS; Yao, X; Yung, LM | 1 |
| Brce, J; Doyle, N; Ho, KK; Lee, HJ; Leong, GM; Leung, KC; Sjögren, K | 1 |
| Dougherty, SM; Klinge, CM; Li, Y; Manavalan, TT; Riggs, KA; Wickramasinghe, NS | 1 |
| El Gebeily, G; Fiset, C | 1 |
| Balapure, AK; Gupta, DK; Nigam, D; Nigam, M; Ranjan, V; Sharma, R; Singh, N; Sundaram, S; Zaidi, D | 1 |
5 review(s) available for dactinomycin and tamoxifen
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Implication of prior treatment with drug combinations including inhibitors of topoisomerase II in therapy-related monocytic leukemia with a 9;11 translocation.
Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 9; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Iatrogenic Disease; Leukemia, Monocytic, Acute; Mastectomy, Radical; Middle Aged; Podophyllotoxin; Radiotherapy; Tamoxifen; Topoisomerase II Inhibitors; Translocation, Genetic | 1990 |
Treatment of the carcinoid tumor and the malignant carcinoid syndrome.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Appendectomy; Appendiceal Neoplasms; Carcinoid Tumor; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Embolization, Therapeutic; Female; Fluorouracil; Hepatic Artery; Humans; Hydroxyindoleacetic Acid; Ligation; Liver Neoplasms; Male; Malignant Carcinoid Syndrome; Middle Aged; Rectal Neoplasms; Streptozocin; Tamoxifen | 1983 |
Studies on mechanisms of estrogen and antiestrogen action in human breast cancer.
Topics: Breast Neoplasms; Cell Line; Cell Nucleus; Cytoplasm; Dactinomycin; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogens; Female; Humans; Nafoxidine; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1980 |
Systemic therapy for treating locoregional recurrence in women with breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Combined Modality Therapy; Dactinomycin; Female; Humans; Interferon-alpha; Neoplasm Recurrence, Local; Randomized Controlled Trials as Topic; Tamoxifen | 2001 |
1 trial(s) available for dactinomycin and tamoxifen
| Article | Year |
|---|---|
A randomised controlled trial of adjuvant hormono-chemotherapy in Stage II breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Female; Humans; Mastectomy, Simple; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Random Allocation; Tamoxifen; Vincristine | 1988 |
47 other study(ies) available for dactinomycin and tamoxifen
| Article | Year |
|---|---|
Structure-activity relationships of antineoplastic agents in multidrug resistance.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cricetinae; Dactinomycin; Drug Resistance; Leukemia L1210; Mice; Regression Analysis; Structure-Activity Relationship; Tumor Cells, Cultured | 1990 |
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.
Topics: Adenosine Triphosphatases; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Calcium Channel Blockers; Cyclosporine; Detergents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Humans; Ivermectin; Mice; NIH 3T3 Cells; Substrate Specificity | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
Topics: Candida albicans; Membrane Transport Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Substrate Specificity | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A new, nongenomic estrogen action: the rapid release of intracellular calcium.
Topics: Androgens; Animals; Calcium; Cells, Cultured; Chickens; Cycloheximide; Dactinomycin; Egtazic Acid; Estrenes; Estrogens; Female; Granulosa Cells; Kinetics; Lanthanum; Neomycin; Progestins; Pyrrolidinones; Rats; Rats, Inbred Strains; Swine; Tamoxifen; Time Factors; Transcription, Genetic; Type C Phospholipases | 1992 |
Estradiol-induced increase in number of gonadotropin-releasing hormone receptors in cultured ovine pituitary cells.
Topics: Animals; Cells, Cultured; Cycloheximide; Dactinomycin; Estradiol; Female; Hydrocortisone; Pituitary Gland, Anterior; Progesterone; Protein Biosynthesis; Receptors, LHRH; RNA, Messenger; Sheep; Tamoxifen | 1990 |
Estrogenic and antiestrogenic down-regulation of estrogen receptor levels: evidence for two different mechanisms.
Topics: Breast Neoplasms; Dactinomycin; Down-Regulation; Estradiol; Estrogen Antagonists; Female; Humans; Receptors, Estrogen; Tamoxifen; Tumor Cells, Cultured | 1990 |
[Desmoid fibroma of the scapula. Recurrence with pulmonary metastasis].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dactinomycin; Female; Fibroma; Humans; Ifosfamide; Lung Neoplasms; Neoplasm Recurrence, Local; Scapula; Tamoxifen; Vincristine | 1989 |
Hormonal regulation of synthesis and secretion of pS2 protein relevant to growth of human breast cancer cells (MCF-7).
Topics: Androgens; Breast Neoplasms; Cell Division; Cycloheximide; Dactinomycin; DNA, Neoplasm; Estrogens; Humans; In Vitro Techniques; Nafoxidine; Neoplasm Proteins; Progesterone; Proteins; Tamoxifen; Trefoil Factor-1; Tumor Cells, Cultured; Tumor Suppressor Proteins | 1989 |
Early estrogen-induced metabolic changes and their inhibition by actinomycin D and cycloheximide in human breast cancer cells: 31P and 13C NMR studies.
Topics: Breast Neoplasms; Carbon Isotopes; Cell Line; Clone Cells; Cycloheximide; Dactinomycin; Estradiol; Female; Glucose; Glutamates; Glycolysis; Humans; Lactates; Magnetic Resonance Spectroscopy; Phospholipids; Phosphorus; Tamoxifen; Tumor Cells, Cultured | 1989 |
Transcriptional regulation of c-myc oncogene expression by estrogen in hormone-responsive human breast cancer cells.
Topics: Breast Neoplasms; Cycloheximide; Dactinomycin; DNA; Estradiol; Gene Expression Regulation; Half-Life; Humans; Nucleic Acid Hybridization; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-myc; RNA, Messenger; Tamoxifen; Transcription, Genetic; Tumor Cells, Cultured | 1988 |
The effect of prior adjuvant chemotherapy on survival in metastatic breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Receptors, Estrogen; Retrospective Studies; Tamoxifen; Vincristine | 1988 |
Stimulation by estradiol-17 beta of thymidine kinase activity in the rat uterus.
Topics: Animals; Castration; Dactinomycin; Dose-Response Relationship, Drug; Estradiol; Female; Isoenzymes; Rats; Rats, Inbred Strains; Tamoxifen; Thymidine Kinase; Time Factors; Uterus | 1984 |
In vitro and in vivo interactions of methotrexate and other antimetabolites with the oestrogen high affinity receptors of the rat uterus.
Topics: Animals; Antimetabolites; Cycloheximide; Dactinomycin; Doxorubicin; Estradiol; Female; Methotrexate; Rats; Rats, Inbred Strains; Receptors, Estrogen; Tamoxifen; Uterus | 1983 |
Osteosarcoma following radiation treatment for meningioma: report of a case and effective treatment with chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Cisplatin; Dactinomycin; Etoposide; Female; Gonadotropin-Releasing Hormone; Humans; Ifosfamide; Lung Neoplasms; Meningeal Neoplasms; Meningioma; Methotrexate; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Osteosarcoma; Tamoxifen; Tomography, X-Ray Computed; Vincristine | 1994 |
Tamoxifen aziridine, a novel affinity probe for P-glycoprotein in multidrug resistant cells.
Topics: Affinity Labels; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Cell Line; Colchicine; Cricetinae; Cricetulus; Dactinomycin; Doxorubicin; Drug Resistance; Kinetics; Lung; Membrane Glycoproteins; Tamoxifen; Tritium; Vinblastine; Vincristine | 1994 |
Estradiol-induced down-regulation of estrogen receptor. Effect of various modulators of protein synthesis and expression.
Topics: Cycloheximide; Dactinomycin; Down-Regulation; Estradiol; Estrone; Half-Life; Humans; Intercalating Agents; Kinetics; Molecular Weight; Phosphoric Monoester Hydrolases; Protein Kinase Inhibitors; Protein Synthesis Inhibitors; Receptors, Estrogen; RNA, Messenger; Tamoxifen; Tritium; Tumor Cells, Cultured | 1994 |
Interleukin 6 stimulates the production of immunoreactive endothelin 1 in human breast cancer cells.
Topics: Breast Neoplasms; Cycloheximide; Cytokines; Dactinomycin; Endothelins; Estrogens; Humans; Interleukin-6; Stimulation, Chemical; Tamoxifen; Tumor Cells, Cultured | 1993 |
Estradiol increases cyclic adenosine monophosphate in rat pulmonary vascular smooth muscle cells by a nongenomic mechanism.
Topics: Animals; Calcium; Cyclic AMP; Dactinomycin; Estradiol; Lung; Muscle, Smooth, Vascular; Pertussis Toxin; Rats; Tamoxifen; Virulence Factors, Bordetella | 1996 |
Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells.
Topics: Breast Neoplasms; Cell Division; Dactinomycin; Estradiol; Estrogen Antagonists; Female; Humans; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor I; Plasmids; Protein Synthesis Inhibitors; Receptors, Estrogen; Recombinant Proteins; Signal Transduction; Tamoxifen; Transcriptional Activation; Tumor Cells, Cultured | 1997 |
Transcriptional mechanisms involved in the relaxant effect of zeranol on isolated rat uterus.
Topics: Animals; Cyclic AMP-Dependent Protein Kinases; Cycloheximide; Dactinomycin; Eflornithine; Enzyme Inhibitors; Estrogen Antagonists; Estrogens, Non-Steroidal; Female; In Vitro Techniques; Ornithine Decarboxylase Inhibitors; Protein Synthesis Inhibitors; Rats; Rats, Wistar; Tamoxifen; Transcription, Genetic; Uterus; Zeranol | 1997 |
Estrogen stimulation of creatine kinase B specific activity in 3T3L1 adipocytes after their differentiation in culture: dependence on estrogen receptor.
Topics: 3T3 Cells; Adipose Tissue; Animals; Cell Differentiation; Creatine Kinase; Cycloheximide; Dactinomycin; Dihydrotestosterone; Estradiol; Estrogen Antagonists; Female; Insulin-Like Growth Factor I; Isoenzymes; Kinetics; Male; Mice; Progesterone; Protein Synthesis Inhibitors; Rats; Receptors, Estrogen; Tamoxifen; Transfection | 1997 |
17beta-estradiol stimulates substance P receptor gene expression.
Topics: Animals; Cycloheximide; Dactinomycin; Estradiol; Estrogen Antagonists; Gene Expression; Gene Expression Regulation; Nucleic Acid Synthesis Inhibitors; Protein Binding; Protein Synthesis Inhibitors; Receptors, Estrogen; Receptors, Neurokinin-1; RNA, Messenger; Substance P; Tamoxifen; Tritium; Tumor Cells, Cultured | 1997 |
Hormonal regulation of the androgen receptor expression in human prostatic cells in culture.
Topics: Androgen Antagonists; Cell Nucleus; Cells, Cultured; Coculture Techniques; Cycloheximide; Cyproterone Acetate; Cytoplasm; Dactinomycin; Dihydrotestosterone; Epithelial Cells; Estradiol; Estrogen Antagonists; Fibroblasts; Homeostasis; Humans; Male; Nucleic Acid Synthesis Inhibitors; Prostate; Protein Synthesis Inhibitors; Receptors, Androgen; Tamoxifen | 1998 |
Estrogenic and anti-estrogenic regulation of estrogen receptor in MCF-7 breast-cancer cells: comparison of immunocytochemical data with biochemical measurements.
Topics: Breast Neoplasms; Cycloheximide; Dactinomycin; Down-Regulation; Estradiol; Estrogen Antagonists; Estrogens; Humans; Immunoenzyme Techniques; Immunohistochemistry; Kinetics; Okadaic Acid; Polyunsaturated Alkamides; Receptors, Estrogen; Tamoxifen; Time Factors; Tumor Cells, Cultured | 1998 |
Stimulation of PC cell-derived growth factor (epithelin/granulin precursor) expression by estradiol in human breast cancer cells.
Topics: Blotting, Western; Breast; Breast Neoplasms; Culture Media, Conditioned; Cycloheximide; Dactinomycin; Dose-Response Relationship, Drug; Epithelial Cells; Estradiol; Estrogen Antagonists; Gene Expression Regulation; Glycoproteins; Granulins; Growth Substances; Humans; Intercellular Signaling Peptides and Proteins; Progranulins; Protein Precursors; RNA, Messenger; Tamoxifen; Time Factors; Tumor Cells, Cultured | 1999 |
Estradiol-17beta-BSA stimulates Ca(2+) uptake through nongenomic pathways in primary rabbit kidney proximal tubule cells: involvement of cAMP and PKC.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenine; Amiloride; Animals; Anti-Arrhythmia Agents; Biological Transport; Calcium; Cells, Cultured; Cyclic AMP; Cycloheximide; Dactinomycin; Enzyme Inhibitors; Estradiol; Estrenes; Estrogens, Conjugated (USP); Gallopamil; Kidney Tubules, Proximal; Kinetics; Male; Parathyroid Hormone; Phosphodiesterase Inhibitors; Protein Kinase C; Pyrrolidinones; Rabbits; Serum Albumin, Bovine; Tamoxifen; Tetradecanoylphorbol Acetate | 2000 |
Differential effects of 17beta-estradiol and testosterone on the contractile responses of porcine coronary arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Androgen Antagonists; Androgen Receptor Antagonists; Animals; Coronary Vessels; Cycloheximide; Cyproterone; Dactinomycin; Dose-Response Relationship, Drug; Endothelin-1; Estradiol; Estrogen Antagonists; Female; Flutamide; Fulvestrant; In Vitro Techniques; Isotonic Solutions; Male; Potassium Chloride; Receptors, Estrogen; Serotonin; Swine; Tamoxifen; Testosterone; Vasoconstriction | 2000 |
Estrogen and progesterone modulation of eosinophilic infiltration of the rat uterine cervix.
Topics: Animals; Cervical Ripening; Cervix Uteri; Chemotaxis, Leukocyte; Dactinomycin; Eosinophils; Estrogen Antagonists; Estrogens; Female; Mifepristone; Nucleic Acid Synthesis Inhibitors; Ovariectomy; Pregnancy; Progesterone; Pseudopregnancy; Rats; Rats, Wistar; Tamoxifen | 2000 |
In vivo regulation of syndecan-3 expression in the rat uterus by 17 beta-estradiol.
Topics: Animals; Cycloheximide; Dactinomycin; Dexamethasone; Dihydrotestosterone; Dose-Response Relationship, Drug; Epithelial Cells; Estradiol; Estriol; Female; Gene Expression Regulation; Immunohistochemistry; Membrane Glycoproteins; Organ Specificity; Ovariectomy; Progesterone; Protein Biosynthesis; Proteoglycans; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; RNA, Messenger; Substrate Specificity; Syndecan-3; Tamoxifen; Transcription, Genetic; Uterus | 2001 |
FRAP reveals that mobility of oestrogen receptor-alpha is ligand- and proteasome-dependent.
Topics: Bacterial Proteins; Biological Transport; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Dactinomycin; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Fulvestrant; HeLa Cells; Histone Acetyltransferases; Humans; Leupeptins; Ligands; Luminescent Proteins; Microscopy, Fluorescence; Multienzyme Complexes; Nuclear Matrix; Nuclear Receptor Coactivator 1; Proteasome Endopeptidase Complex; Protein Structure, Tertiary; Receptors, Estrogen; Tamoxifen; Transcription Factors; Transcription, Genetic | 2001 |
Estrogen receptor alpha mediated induction of the transforming growth factor alpha gene by estradiol and 4-hydroxytamoxifen in MDA-MB-231 breast cancer cells.
Topics: Blotting, Northern; Blotting, Western; Cycloheximide; Dactinomycin; DNA, Complementary; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Humans; Luciferases; Protein Synthesis Inhibitors; Receptors, Estrogen; RNA, Messenger; Signal Transduction; Tamoxifen; Time Factors; Transcription, Genetic; Transfection; Transforming Growth Factor alpha; Tumor Cells, Cultured | 2001 |
Steroid hormonal regulation of proliferative, p53 tumor suppressor, and apoptotic responses of sheep ovarian surface epithelial cells.
Topics: Animals; Apoptosis; Cell Division; Cells, Cultured; Dactinomycin; DNA Damage; DNA Fragmentation; DNA Replication; Epithelial Cells; Estradiol; Female; Immunohistochemistry; Ovary; Progesterone; Sheep; Tamoxifen; Time Factors; Tumor Suppressor Protein p53 | 2002 |
Resveratrol activates adenylyl-cyclase in human breast cancer cells: a novel, estrogen receptor-independent cytostatic mechanism.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Adenylyl Cyclases; Antineoplastic Agents, Phytogenic; Arachidonic Acids; Breast Neoplasms; Cell Division; Cyclic AMP; Cyclic GMP; Dactinomycin; Enzyme Activation; Enzyme Inhibitors; Female; Guanylate Cyclase; Humans; Receptors, Estrogen; Resveratrol; Rolipram; Stilbenes; Tamoxifen; Tumor Cells, Cultured | 2003 |
Mechanisms of diethylstilbestrol-induced relaxation in rat aorta smooth muscle.
Topics: Animals; Aorta, Thoracic; Cyclic AMP-Dependent Protein Kinases; Cycloheximide; Dactinomycin; Diethylstilbestrol; Enzyme Inhibitors; Estrogen Antagonists; Estrogens, Non-Steroidal; Extracellular Space; In Vitro Techniques; Male; Muscle Relaxation; Muscle Tonus; Muscle, Smooth, Vascular; Norepinephrine; Ornithine Decarboxylase Inhibitors; Pertussis Toxin; Propranolol; Protein Kinase C; Protein Synthesis Inhibitors; Rats; Rats, Wistar; Second Messenger Systems; Tamoxifen; Vasoconstrictor Agents; Vasodilator Agents | 2003 |
Evidence that 17alpha-estradiol is biologically active in the uterine tissue: antiuterotonic and antiuterotrophic action.
Topics: Animals; Calcium Chloride; Cycloheximide; Dactinomycin; Estradiol; Estrogens; Female; Fulvestrant; In Vitro Techniques; Muscle Relaxation; Norepinephrine; Potassium Chloride; Propranolol; Rats; Rats, Wistar; Stereoisomerism; Tamoxifen; Uterine Contraction; Uterus | 2005 |
Estrogen receptor-alpha mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen.
Topics: Cell Line, Tumor; Cell Proliferation; Cycloheximide; Dactinomycin; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Oligonucleotide Array Sequence Analysis; Ovarian Neoplasms; Response Elements; RNA Stability; RNA, Messenger; Tamoxifen | 2005 |
Diffuse thoracic lymphangiomatosis with disseminated intravascular coagulation in a child.
Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disseminated Intravascular Coagulation; Dyspnea; Fatal Outcome; Female; Humans; Lymphangioma; Mediastinum; Palliative Care; Radiotherapy, Adjuvant; Tamoxifen; Thoracic Neoplasms; Thrombocytopenia; Vincristine | 2005 |
Tamoxifen dilates porcine coronary arteries: roles for nitric oxide and ouabain-sensitive mechanisms.
Topics: Animals; Calcium; Coronary Vessels; Cycloheximide; Dactinomycin; Estradiol; Free Radical Scavengers; Nitric Oxide; Nitric Oxide Synthase Type III; Nitroprusside; Ouabain; Phosphorylation; Potassium Channel Blockers; Swine; Tamoxifen | 2006 |
Regulation of growth hormone signaling by selective estrogen receptor modulators occurs through suppression of protein tyrosine phosphatases.
Topics: Breast Neoplasms; Cell Line, Tumor; Dactinomycin; Estrogen Antagonists; Estrogens; Human Growth Hormone; Humans; Intracellular Signaling Peptides and Proteins; Janus Kinase 2; Kidney; Protein Synthesis Inhibitors; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein Tyrosine Phosphatases; Raloxifene Hydrochloride; Receptors, Estrogen; Signal Transduction; STAT5 Transcription Factor; Suppressor of Cytokine Signaling Proteins; Tamoxifen | 2007 |
Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells.
Topics: 3' Untranslated Regions; Apoptosis Regulatory Proteins; Breast Neoplasms; Cell Line, Tumor; Cycloheximide; Dactinomycin; Down-Regulation; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; MicroRNAs; Nucleic Acid Synthesis Inhibitors; Promoter Regions, Genetic; Protein Synthesis Inhibitors; ras GTPase-Activating Proteins; RNA-Binding Proteins; RNA, Antisense; Tamoxifen | 2009 |
4-Hydroxytamoxifen inhibits K(+) currents in mouse ventricular myocytes.
Topics: Animals; Dactinomycin; Electric Conductivity; Estradiol; Female; Fulvestrant; Heart Ventricles; Kinetics; Mice; Muscle Cells; Patch-Clamp Techniques; Potassium; Receptors, Estrogen; Tamoxifen; Transcription, Genetic | 2010 |
Centchroman mediated apoptosis involves cross-talk between extrinsic/intrinsic pathways and oxidative regulation.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Caspases; Cell Cycle; Cell Line, Tumor; Centchroman; Cycloheximide; Dactinomycin; Down-Regulation; Estrogen Antagonists; Female; Humans; Immunoprecipitation; Oxidative Stress; Tamoxifen; Up-Regulation | 2010 |